Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Nov 07 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-nov-07-2023-15

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 07, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval forFluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10mg".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

In the deck

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases